Company Profile

Medical Conservation Devices Inc
Profile last edited on: 12/21/19      CAGE: 4XPG5      UEI:

Business Identifier: Respiratory therapy medical device development
Year Founded
2005
First Award
2009
Latest Award
2011
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

99 MedTech Drive
Batavia, NY 14020
Location: Single
Congr. District: 27
County: Genesee

Public Profile

Medical Conservation Devices Inc, a spin out of First Wave Technologies, was founded in order to develop and ultimately commercialize a series of proprietary and patented respiratory therapy medical devices. The first commercial product from MCD is a medical device developed for the delivery and conservation of inhaled drugs and medical gases to patients requiring advanced ventilation support, making delivery of inhaled anesthetics practical for the first time for infectious patients and those with severe lung injury. The device can be manufactured either as a disposable or reusable product and can work with any existing ventilator or configured as a ventilator itself. The firm plans to extend this initial technology to deliver therapeutic and sedative medications and improve standard of care for pediatrics, ICU, and hard-to-sedate patients. An estimated addressable market of $1.2 billion exists in these applications alone. Additionally, these devices can be multiplexed allowing up to 8 patients to be ventilated off of a single respirator. The value proposition to hospitals facing limited ventilation and anesthesia resource is clear and compelling.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2011 1 DHA $150,000
Project Title: Self-Regulating Anesthesia/Analgesia Device Using Automated Fresh Gas Flow to Deliver Inhaled Agents
2011 2 NIH $873,521
Project Title: Pandemic Or Mass Casualty Aseptic Shared Ventilation

Key People / Management

  Brian Bell -- Chief Executive Officer

  Charles Kenton Akers -- Former Technical Director